Effects of low-dose aspirin in subjects with dyslipidemia

BACKGROUND: To evaluate the efficacy and safety of aspirin usage for coronary heart disease (CHD) primary prevention in patients with dyslipidemia. METHODS: A cross-sectional study was conducted to enrolled subjects with documented dyslipidemia. A total of 202 patients with dyslipidemia were recruit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Guozhong, Chen, Jianming, Xia, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910210/
https://www.ncbi.nlm.nih.gov/pubmed/27313113
http://dx.doi.org/10.1186/s12944-016-0274-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910210/
https://www.ncbi.nlm.nih.gov/pubmed/27313113
http://dx.doi.org/10.1186/s12944-016-0274-8

Ejemplares similares